false
0001939365
0001939365
2025-08-20
2025-08-20
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
August 20, 2025
INSPIRE VETERINARY PARTNERS, INC.
(Exact name of registrant as specified in its charter)
| Nevada |
|
001-41792 |
|
85-4359258 |
| (State or other jurisdiction |
|
(Commission File Number) |
|
(I.R.S. Employer |
| of incorporation) |
|
|
|
Identification No.) |
780 Lynnhaven Parkway, Suite 400
Virginia Beach, VA |
|
23452 |
| (Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (757) 734-5464
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common stock, par value $0.0001 |
|
IVP |
|
Nasdaq Capital Market |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 8.01 Other Events.
As previously disclosed, on April 10, 2025,
Inspire Veterinary Partners, (the “Company”) received a notice letter (the “Notice”) from the Listing Qualifications
Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based on the Company’s stockholders’
equity of $1,562,005, as reported in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, the Company
is no longer in compliance with the minimum stockholders’ equity requirement for continued inclusion on the Nasdaq Capital Market
under Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Requirement”).
The Company had 45 calendar days from the date of the Notice to submit
its plan to regain compliance to Nasdaq, which was submitted on May 23, 2025.
Also, as previously disclosed, on July 28, 2025, the Company entered
into a Securities Purchase Agreement with certain accredited investors for of up to 7,590 shares of Series B convertible preferred
stock (“Series B Preferred Stock”) and accompanying warrants (“Warrants”) to purchase shares of the Company’s
common stock (the “Private Placement”). The aggregate offering amount is up to $10 million, to be completed in one or
more closings.
On July 29, 2025, the Company completed the first closing of the Private
Placement, issuing 6,340 shares of Series B Preferred Stock and 6,340,000 Warrants for aggregate proceeds of approximately
$5 million. Proceeds were received in cash and through the transfer of certain securities in lieu of cash.
As of the date of this Report on Form 8-K, the Company believes, as
a result of the first closing of the Private Placement, it has regained compliance with the Stockholders’ Equity Requirement.
Nasdaq will continue to monitor the Company’s ongoing compliance
with the stockholders’ equity requirement and, if at the time of its next periodic report the Company does not evidence compliance,
it may be subject to delisting.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: August 20, 2025 |
INSPIRE VETERINARY PARTNERS, INC. |
| |
|
| |
By: |
/s/ Kimball Carr |
| |
Name: |
Kimball Carr |
| |
Title: |
President and Chief Executive Officer |
2
